News & Articles

University of California San Francisco (UCSF) uses Phenoptics™ platform to help with biomarker discovery

Collaboration to develop stem cell therapies for COVID-19 and future pandemic diseases

Developed with enhanced technology, this new assay provides high-quality staining with improved turnaround time

A team of British and American scientists have discovered a way to slow the growth of breast cancer stem cells in the lab

Researchers from the University of Oxford’s Department of Zoology have discovered that moderate doses of antibiotics restrict the emergence of antibiotic-resistant bacteria

This support will contribute to the measures against COVID-19, following provision of medical equipment and supplies, employee donations, and loans through NPO

This recognition occurred at the 2020 NACCHO Annual Conference virtually July 7-9, 2020

Patented PrimeStore MTM technology is designed to enable safe sample handling and testing for multiple pathogens from one sample swab

Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan

The acquisition aims to strengthen LGC’s existing product offering to the in vitro diagnostics sector

How Radboud University Medical Center researchers have identified protein biomarkers linked to COVID-19 infection

Prof. Tone Frost Bathen explores how to enhance clinical research through standardization, validation and data sharing

Researchers suggest cortisol levels can be used to identify those patients who are more likely to need intensive care

Download this application note from Sartorius to discover how the need to monitor T cell phenotype and function for improved T cell expansion protocols was addressed with a T cell memory cell and cytokine profiling assay

Researchers are to assess the effectiveness of tests that may give doctors COVID-19 results in minutes rather than days

New research assesses the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin

The production agreement is part of AstraZeneca’s recently announced in-licensed programme with the University of Oxford

Exclusive interviews, new methods, free downloads and much more to help advance your cancer research

Join us on Monday, June 22, to learn how Olink’s latest immunoassay technology is taking proteomics to a new level

Results from prospective trials show a “clear prognostic value” for CTC counts

Olink Proteomics have announced the launch of Olink® Explore 1536

Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events

The CE-IVD marked system will enable diagnostic pathologists with new applications

Science industry comes together online to share knowledge and provide technology solutions for cancer and immunology research